Physician profile
Taylor S Long
NPI 1326655416
$1,250.59
in general payments reported to CMS, 2019-2025
14 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $277 · 2022: $361 · 2023: $208 · 2024: $273 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $613.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $613.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $269.89 | 2021-2025 | Repatha, Repatha, Otezla |
| Novartis Pharmaceuticals Corporation | $242.17 | 2022-2024 | |
| Glaxosmithkline, LLC. | $195.00 | 2023-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Novo Nordisk INC | $155.01 | 2022-2024 | Wegovy |
| Astrazeneca Pharmaceuticals LP | $145.03 | 2021-2023 | Farxiga |
| Sumitomo Pharma America, INC. | $36.91 | 2025 | Gemtesa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.24 | 2021-2024 | Jardiance |
| Esperion Therapeutics, INC. | $33.11 | 2024 | Nexletol |
| Abbvie INC. | $32.02 | 2024-2025 | |
| Boston Scientific Corporation | $24.73 | 2021 | |
| Cvrx, INC. | $24.10 | 2023 | Barostim Neo System |
| Exact Sciences Corporation | $20.18 | 2024 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $18.42 | 2021 | |
| Dexcom, INC. | $17.78 | 2024 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Long listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.